{"id":"W2891970367","doi":"10.1136/annrheumdis-2018-eular.1202","title":"SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Regeneron Pharmaceuticals; Celltrion; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Rheumatic disease; Antirheumatic Agents; Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005144937,0.0004134586,0.0008868251,0.0002104863,0.0001795088,0.0005435096,0.0002627388,0.0003384433,0.003482716],"category_scores_gemma":[0.0008353107,0.0001176094,0.00118441,0.0002965689,0.0002011299,0.0003505183,0.000304343,0.0007325069,0.0004525291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003496429,"about_ca_system_score_gemma":0.0005387694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001294103,"about_ca_topic_score_gemma":0.004848171,"domain_scores_codex":[0.9997941,0.00005782794,0.00002116232,0.00003563358,0.00004371993,0.00004748751],"domain_scores_gemma":[0.999574,0.0001084972,0.0001526587,0.00002484316,0.00004615849,0.00009385472],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2574787,0.008409527,0.1560868,0.002319955,0.01154557,0.0002673313,0.0001348761,0.001700444,0.007518916,0.0004730445,0.01986514,0.5341997],"study_design_scores_gemma":[0.1783535,0.09081465,0.6826512,0.0007734753,0.01813192,0.001935826,0.0004238331,0.003865223,0.003711888,0.001074572,0.01809748,0.0001664832],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825377,0.01065785,0.0001524928,0.0006263614,0.0001387158,0.000104664,0.002185976,0.00005360964,0.003542764],"genre_scores_gemma":[0.9871047,0.005633104,0.000535493,0.0009257415,0.0002570017,0.0001347286,0.004093241,0.000009613252,0.001306347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003482716,"threshold_uncertainty_score":0.01165086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02030599282964591,"score_gpt":0.2802099168111502,"score_spread":0.2599039239815043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}